喉部分切除术后肌-骨膜瓣修复术  

Laryngeal reconstruction with the sternohyoid muscle-periosteum flap following partial laryngectomy

作　　者：王亚康[1] 谢宏武[1] 邓俊[1] 包小庆[1] 汪旭芳[1] 

机构地区：[1]安徽省安庆市立医院耳鼻咽喉科,246003

出　　处：《中国中西医结合耳鼻咽喉科杂志》2007年第6期434-435,共2页Chinese Journal of Otorhinolaryngology in Integrative Medicine

摘　　要：目的探讨喉部分切除术后胸骨舌骨肌-骨膜瓣修复残喉的手术方法及其临床疗效。方法对1992年2月～2004年4月在我院行垂直喉部分切除联合胸骨舌骨肌-骨膜瓣修复术的26例声门型喉癌患者进行回顾性研究,分析其临床资料,总结临床疗效。结果本组病例1、3、5年生存率分别为100%(26/26)、96.15%(25/26)和88.0%(22/25);拔管率为100%。全部病例均经口正常饮食;尽管存在不同程度声嘶,但发音功能恢复,可以进行日常生活性交流。病变复发率为7.69%(2/26)。结论垂直喉部分切除术后应用带蒂胸骨舌骨肌-骨膜瓣修复残喉,简便易行,能够较好地保留喉的生理功能。Objective To investigate the operating procedures of laryngeal reconstruction with sternohyoid muscle - periosteum flap following partial laryngectomy and to observe the clinical therapeutic effects of this surgery on the cases received this kind of therapy. Methods A retrospective study was carried out among 26 cases with glottic carcinoma treated by vertical partial laryngectomy followed by laryngeal reconstruction with sternohyoid muscle-periosteum flap from Feb. 1992 to Apr. 2004 in our Hospital. Their clinical data were carefully analyzed to sum up the long-term outcome of this therapy on these cases and the clinical experience with this surgery.Results The survival rates of 1-,3- and 5-year were 100% （26/26）, 96.15% （25/26） and 88.0% （22/25） respectively, with a detubation rate of 100% for these patients. All these patients could＇ take in food via normal mouth way and recovered vocal function to communicate with others in daily life following the surgery, though with various degrees of hoarseness. By the end of following up period, only found with a reoccurring rate of 7.69% （2/26） was the lesion for this group of eases. Conclusions The procedures of laryngeal reconstruction with sternohyoid muscle-periosteum flap following vertical partial laryngectomy are simple es with in operation and the laryngeal function can be reserved much better following this therapy for those easglottic carcinoma.

关 键 词：喉癌 喉部分切除术 肌瓣修复 发音功能重建 

分 类 号：R739.6[医药卫生—肿瘤]